Navigation Links
Zix Corporation Selected by Houston Healthcare for Email Encryption Service
Date:4/7/2009

Georgia-based health system to deploy ZixCorp's email encryption services

DALLAS, April 7 /PRNewswire-FirstCall/ -- Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Houston Healthcare, a Georgia-based health system, has signed a three-year contract for the company's email encryption services.

ZixCorp will enforce Houston Healthcare's email encryption policies to ensure the secure handling of confidential information. The service includes a pre-configured lexicon that automatically detects and encrypts protected health information ("PHI"). ZixCorp will also provide branding and encrypted messaging functionality to the organization's website.

"ZixCorp's services are the proven choice for the healthcare industry," said Rob Rhodes, chief information officer for Houston Healthcare. "After reviewing ZixCorp's customer base and excellent recommendations from references and consultants, we're confident our choice was the right one."

"ZixCorp's email encryption services continue to be the first choice in the healthcare community because of the ZixDirectory and our ability to deliver key management in the cloud," said Rick Spurr, chief executive officer for ZixCorp. "As the only significant hosted service for email encryption, we can uniquely provide immediate access to a large community of users in a highly scalable and easy-to-deploy manner."

ZixCorp offers the simplicity of Software as a Service ("SaaS") with the convenience of customizable encryption policies. ZixCorp operates the largest email encryption directory in the world enabling seamless and secure communication among communities of interest. ZixCorp's directory connects over 15 million members and includes 20 state banking regulators, over 800 financial institution
'/>"/>

SOURCE Zix Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...te (TM) has been shown in studies to be effective ...ed by an overload of copper, and certain metastati...r, is known about how the drug works at the molecu...versity researchers now has provided an invaluable... to copper-loaded metallochaperones. The drug sequ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...wswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. ...will host two investor events in December: ,, ....m. CT/10:00 a.m. ET ,, Principal investigato...filzomib in relapsed and/or refractory multiple my... Hematology (ASH) Annual Meeting and Exposition in...
(Date:11/25/2009)...USNewswire/ -- The Black AIDS Institute recently h...tive leadership for 2010. ,, The new Board Memb...cialties in public policy, law, finance, governmen...eneurship. The Board also comes from a wide range ...l and gay Black men and women, some living with HI...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ALE, N.Y., May 11 Misonix, Inc. (Nasdaq: MSON )...ical device technology, which in Europe is used fo...cute health conditions, today reported financial r...r VP and Chief Financial Officer, will host a conf...
...TON, May 11, 2009 News media registration for one...eetings is now open. The 238th National Meeting & ...will be held Aug. 16-20, 2009, in Washington, D.C....ude more than 8,400 reports on new discoveries abo...
...ality videoconferencing can increase patient acces...her underserved areas; and a transient ischemic at...roke, should be treated with the same urgency as a...ssociation . , Telemedicine Statement Highlights...
...er Hair Removal System Called a "Medical Must Have...e leader in at-home aesthetic devices, was feature... popular national daytime show that offers viewers...emoval System was included in a segment that showc...
...N, N.J., May 11 Derma Sciences, Inc. (OTC Bul...are products, announced plans to release its first... 18, 2009. The Company will hold a conference cal...asscode 98098954 to access the call. You may also ...
...te-stage cancer greater in city dwellers than in r...y 11 (HealthDay News) -- Living in the city could ...much later stages of their development, new resear...ncer later in the disease,s progression than their...
Other Medicine News:Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 2Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 3Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 4Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 5Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 6Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 7Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 8Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 9Health News:Misonix Reports Earnings for the Three and Nine Months Ended March 31, 2009 10Health News:Videoconferencing can increase patient access to stroke specialists 2Health News:Videoconferencing can increase patient access to stroke specialists 3Health News:TRIA Laser Hair Removal System Debuts on 'The Doctors' 2Health News:Derma Sciences Announces Date of Its First Quarter 2009 Earnings Release and Conference Call 2Health News:Where You Live May Affect Your Cancer Diagnosis 2
(Date:11/25/2009)...RNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABA...t-of-care blood analysis systems, announced today ...officer, will present at the 21st Annual Piper Jaf... 2, 2009 at 2:00 p.m. ET. The conference will be h... ,, About Abaxis ,, Abaxis develops, manu...
(Date:11/25/2009)...RNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: N...ing products for minimally disruptive surgical tre...l host a conference call on Monday, November 30, 2...ce call will focus on current issues relative to r...nclude comments from management followed by a shor...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...very-USMarketTrends&Analysis http://www.repor...-Market-Trends--Analysis.html ,, TheUSintranas...peuticapplicationsfromthedeliveryofconventionalloc...icdrugs.Thefutureofthetechnologyhingesontotheeffec...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5University of Louisville neuroscientists hope to get people walking again 58667 1Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 1Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 2Frozen assets 3A NIAID researchers turn to unique resource for clues to norovirus evolution 10218 3Experts gather at McGill University to address food security challenges 10216 1
...m, January 19 , - New Funds to Drive Clinical...l-Based Therapy for Heart Failure , Cardio3 Bi... specialising,in cell-based therapies for the trea...2 million in a successful Series B fund raising ro...f new and existing investors, will be,used to fina...
...rin Co., Ltd. (Chiyoda-ku, Tokyo Japan; President,...o Time) that it has decided to continue the domest... disease drug KW-6002 (generic name: Istradefyllin...al in Japan. , , KW-6002 has a novel mechanism of...e A2A receptor. Kyowa Hakko Kirin initiated the cl...
Other Medicine Technology:Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 2Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 3Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 4Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 5Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinson's Disease Drug KW-6002 (Istradefylline) 2
... LD400 FT is an affordable full-field, autoperimet...g exam time by at least 40%. It has a small footpr...rapid setup and easy two-button operation making i...endly. The LD 400 FT is the workhorse of the Parad...
...Clear Corneal Diamond Knife is a unique design dev...anta Maria, California. This special knife was cre...rument that could be used in performing his Clear ...ollaboration between KOI and Dr. Shepard, this kni...
...g ClosureWire Vascular Closure System (VCS) utiliz...c Compression., ,The Boomerang ClosureWire tec... the inside of the arteriotomy and just outside th...ompression of both the arteriotomy and tract. The ...
EndoProbe Handpieces
Medicine Products: